Short term follow-up of prediabetics undergoing elective percutaneous coronary intervention

Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. <www.cdc.gov/diabetes/pubs/pdf/ndfs2007.pdf>; 2009 [accessed August 30]. Tapp, 2006, AusDiab study group. Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia, Diabetes Res Clin Pract, 73, 315, 10.1016/j.diabres.2006.02.008 Wong, 2008, Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies, Lancet, 371, 736, 10.1016/S0140-6736(08)60343-8 Association American Diabetes, 2008, Economic costs of diabetes in the US in 2007, Diabetes Care, 31, 561 Haffner, 2000, Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state, Circulation, 101, 975, 10.1161/01.CIR.101.9.975 Wilson, 2005, Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus, Circulation, 112, 3066, 10.1161/CIRCULATIONAHA.105.539528 Knowler, 2002, Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512 Gertein, 2006, DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication). Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial, Lancet, 368, 1096, 10.1016/S0140-6736(06)69420-8 Li, 2008, The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study, Lancet, 371, 1783, 10.1016/S0140-6736(08)60766-7 Lindström, 2006, Finnish diabetes prevention study group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the finish diabetes prevention study, Lancet, 368, 1673, 10.1016/S0140-6736(06)69701-8 Gillies, 2007, Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis, BMJ, 334, 299, 10.1136/bmj.39063.689375.55 Chiasson, 2003, STOP-NIDDM trial research group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial, JAMA, 290, 486, 10.1001/jama.290.4.486 Ratner, 2005, Diabetes prevention program research group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program, Diabetes Care, 28, 888, 10.2337/diacare.28.4.888 AACE Diabetes Mellitus Clinical Practice Guidelines Task Force, 2007, American Association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus, Endocr Pract, 13, 1 American Diabetes Association, 2008, Standards of medical care in diabetes-2008, Diabetes Care, 31, 12, 10.2337/dc08-S012 ACE/AACE consensus statement, 2008, Diagnosis and management of prediabetes in the continuum of hyperglycemia, Endo Pract, 14, 933 Centers for Disease Control and Prevention. <www.cdc.gov/healthyweight/assessing/bmi/>. Accessed August 30, 2009. Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms, Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Lima-Filho, 2010, Predictors of restenosis after percutaneous coronary intervention using bare-metal stents. A comparison between patients with and without dysglycemia, Braz J Med Biol Res, 43, 572, 10.1590/S0100-879X2010007500051 Kato, 2000, Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan: the funagata diabetes study, J Diabetes Complications, 14, 78, 10.1016/S1056-8727(00)00074-X Herder, 2010, Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism. The finnish diabetes prevention study, Nutr Metab Cardiovasc Dis, 18, 60 O’Neill, 2004, Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention, J Am Coll Cardiol, 43, 8, 10.1016/j.jacc.2003.06.019 Serruys, 2005, Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial, J Am Coll Cardiol, 46, 575, 10.1016/j.jacc.2004.12.082 Corpus, 2005, Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization, Am J Cardiol, 92, 1282, 10.1016/j.amjcard.2003.08.008